Trial intelligence / Profile preview

Low-dose pegylated interferon alfa-2b added to standard-dose dasatinib in newly diagnosed chronic phase CML

2011-005989-38Phase 2Completed

Sponsor

Norwegian University of Science and Technology

Start

May 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1